1 / 19

Vascular Biology of Nitric Oxide

PHM142 Fall 2013 Instructor: Dr. Jeffrey Henderson. Vascular Biology of Nitric Oxide. Toby Lee Patricia Lu Kevin Sun Hennie Wei September 25, 2013. Agenda. Synthesis Effect of NO on: Vascular smooth muscle Platelets Vascular smooth muscle cell proliferation

rona
Télécharger la présentation

Vascular Biology of Nitric Oxide

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PHM142 Fall 2013 Instructor: Dr. Jeffrey Henderson Vascular Biology of Nitric Oxide Toby Lee Patricia Lu Kevin Sun Hennie Wei September 25, 2013

  2. Agenda • Synthesis • Effect of NO on: • Vascular smooth muscle • Platelets • Vascular smooth muscle cell proliferation • Oxidant/antioxidant properties • Endothelial cell proliferation and apoptosis • Regulation • Relevant drugs

  3. Synthesis • NO synthase responsible for synthesizing NO • 3 isoforms, endothelial NOs (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) • High homology in domains • Enzyme structure: • Dimer with 2 identical monomers • Each monomer has 2 major domains: • Arginine converted through intermediate to L-citrulline and NO

  4. Synthesis

  5. Synthesis • Reaction that converts L-arginine to L-citrulline • The reaction: • Two step oxidation reaction converts L-arginine to L-citrulline • Initial hydroxylation of L-arginine, forms hydroxy-L-arginine (also substrate for NOS) • Oxidation of intermediate using single electron from NADPH to form L-citrulline and NO • Uses O2 and NADPH • O2 is incorporated into both NO and citruilline • Also requires 4 other coenzymes/cofactors • Protoporphyrin IX haem • FMN • FAD • BH­4 (tetrahydrobiopterin)

  6. Review of Smooth Muscle Contraction

  7. Vascular Tone • Causes relaxation of vascular smooth muscle cells • Shown that inhibition of NO synthesis in vasculature elevates blood pressure • Vasodilation • Basal release of NO critical for vascular tone • NO produced in endothelium diffuses into vascular smooth muscle cells in blood vessels and binds to soluble guanylylcyclase • Activation of GC increases cytosoliccGMP • Signal transduction events lead to a decrease in intracellular calcium

  8. Review of Platelets • Small and disk-shaped (2-4 μm in diameter) • Circulate in blood and involved in hemostasis • Platelet adhesion, aggregation, and recruitment

  9. The Role of NO in Platelets • NO inhibits platelet adhesion, aggregation, and recruitment • Mechanism of Action

  10. The Role of NO in Vascular Smooth Muscle Cell Proliferation • VSMC proliferation is usually involved with atherosclerosis • NO inhibits proliferation of VSMC • Mice study done by Moroi et al., 1998 • Mechanism of Action 1 • Mechanism of Action 2 • NO can upregulate Fas expression on VSMC

  11. Other Properties of NO • NO is a free radical which induces superoxide dismutase expression • Catalyzes the dismutation of superoxide into hydrogen peroxide • Hydrogen peroxide increases the expression of nitric oxide synthase • Increased reduction of oxidative stress • Indirect pathways • Upregulation of heme-oxygenase I • Production of bilirubin, which scavenges superoxide • Increased expression of ferritin • Reduces superoxide formation

  12. Endothelial Cell Protection From NO • Low NO concentration • cGMP dependent • Inhibition of cytochrome c release • cGMP independent • Upregulation of bcl-2 expression • Inactivation of caspases through s-nitrosation • Antioxidant properties • Removal of reactive oxygen species

  13. Endothelial Cell Apoptosis Due To NO • High NO concentration due to oxidative stress, pathogenic NO + O2-ONOO- • DNA damage, protein damage and lipid peroxidation • Prevented by competition with superoxide dismutase • p53 response • Cell cycle arrest by p21 upregulation • Apoptosis, cytochrome c release and caspase activation

  14. Reactivity in body • NO reacts with Heme of erythrocyte hemoglobin • Heme of GuanylylCyclase • dephosphorylates GTP to cGMP • This acts to scavenge NO by hemoglobin https://scontent-a-iad.xx.fbcdn.net/hphotos-ash3/1240264_10200342135030525_309408347_n.jpg

  15. Regulation of NO • Cofactors: NADPH, flavin adenine nucleotides, etc • eNOS activity is calcium- and calmodulin-dependent • Basally active • flow dependent NO formation • receptor stimulated NO formation • iNOS basal activity is very low • during inflammation by bacterial endotoxins and cytokines

  16. Regulation of NOS • eNOSupregulation • NO insufficiency • atherosclerotic burden, endothelial dysfunction • E.g., increased oxidative stress • Target of: Cardiovascular disease drugs (statins, calcium channel blockers) • eNOSdownregulation • Responsible for cardiovascular side effects of glucocorticoids • Notable drug : Viagara • inhibits breakdown of cGMP via inhibiting cGMP dependent phosphodiesterases • antiplatelet and antiaggregatory effects in the blood https://fbcdn-sphotos-e-a.akamaihd.net/hphotos-ak-prn2/1235489_10200342032547963_1348001150_n.jpg

  17. Summary • NO synthase responsible for synthesizing NO • Reaction that converts L-arginine to L-citrulline • Two step oxidation reaction • Uses O2 and NADPH • Also requires 4 other coenzymes/cofactors • Protoporphyrin IX haem • FMN • FAD • BH­4 (tetrahydrobiopterin) • Causes relaxation of vascular smooth muscle cells • Vasodilation • NO causes decrease of intracellular Ca2+ through G protein coupled signal transduction which down regulates smooth muscle contraction • NO inhibits platelet adhesion, aggregation, and recruitment • NO inhibits proliferation of VSMCs • High concentrations produce oxidative species that promote cell death • Heme groups has affinity for NO • eNOS activity is calcium- and calmodulin-dependent and is basally active, either flow dependent or receptor stimulated • iNOS is induced during inflammation by toxins and has low basal activity • NO insufficiency and cardiovascular drugs cause eNOSupregulation: to increase NO production • Viagara inhibits cGMPphosphodiesterase to prolong NO effects = helps smooth muscle relaxation

  18. References Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: Structure, function and inhibition. Biochem J. 2001;357(Pt 3):593-615. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res. 1999;43(3):521-531. Jin RC, Loscalzo J. Vascular nitric oxide: Formation and function. J Blood Med. 2010;2010(1):147-162. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298 ( Pt 2)(Pt 2):249-258. Harrison P. Progress in the assessment of platelet function. Br J Haematol. 2000;111(3):733-744. Moroi M, Zhang L, Yasuda T, et al. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest. 1998;101(6):1225. Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA. Effect of nitric oxide synthase inhibition on bleeding time in humans. J CardiovascPharmacol. 1995;26(2):339-342. Walford G, Loscalzo J. Nitric oxide in vascular biology. Journal of Thrombosis and Haemostasis. 2003;1(10):2112-2118. Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide. 2002;7(3):149-164. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric-oxide synthaseisoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther. 2001;298(2):679-685. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. BiochemBiophys Res Commun. 2001;282(5):1075-1079. KalyanaramanB. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol. 2013;1(1):244-257. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147 Suppl 1:S193-201.

More Related